APO Research
Talk to an analyst

APO RESEARCH · REPORT

Radiation Injury Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Radiation Injury Drugs Market Analysis and Forecast 2026-2032

19 December 2025193 pages

Choose your research edition.

Industry ResearchRadiation Injury Drugs Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Radiation Injury Drugs Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Radiation Injury Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Radiation Injury Drugs Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Radiation Injury Drugs Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Radiation Injury Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Radiation Injury Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Radiation Injury Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Radiation Injury Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Radiation Injury Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Radiation Injury Drugs include Windtree Therapeutics Inc, Tonix Pharmaceuticals Holding Corp, Synedgen Inc, PharmaIN Corp and FirstString Research Inc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Radiation Injury Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Radiation Injury Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Radiation Injury Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Radiation Injury Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Radiation Injury Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Radiation Injury Drugs sales, projected growth trends, production technology, application and end-user industry.

Radiation Injury Drugs Segment by Company

Windtree Therapeutics Inc

Tonix Pharmaceuticals Holding Corp

Synedgen Inc

PharmaIN Corp

FirstString Research Inc

Radiation Injury Drugs Segment by Type

DG-3

Des-Asp Angiotensin 1

C-2E5

C-2E2

BMX-001

Aerosurf

Others

Radiation Injury Drugs Segment by Application

Hospital

Clinic

ASCs

Others

Radiation Injury Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiation Injury Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Radiation Injury Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiation Injury Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Radiation Injury Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Radiation Injury Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Radiation Injury Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Radiation Injury Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. DG-3 Major Manufacturers Table 3. Des-Asp Angiotensin 1 Major Manufacturers Table 4. C-2E5 Major Manufacturers Table 5. C-2E2 Major Manufacturers Table 6. BMX-001 Major Manufacturers Table 7. Aerosurf Major Manufacturers Table 8. Others Major Manufacturers Table 9. Global Radiation Injury Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 10. Hospital Major Manufacturers Table 11. Clinic Major Manufacturers Table 12. ASCs Major Manufacturers Table 13. Others Major Manufacturers Table 14. Radiation Injury Drugs Industry Trends Table 15. Radiation Injury Drugs Industry Drivers Table 16. Radiation Injury Drugs Industry Opportunities and Challenges Table 17. Radiation Injury Drugs Industry Restraints Table 18. Global Radiation Injury Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Radiation Injury Drugs Revenue by Region (2021-2026) & (US$ Million) Table 20. Global Radiation Injury Drugs Revenue by Region (2027-2032) & (US$ Million) Table 21. Global Radiation Injury Drugs Revenue Market Share by Region (2021-2026) Table 22. Global Radiation Injury Drugs Revenue Market Share by Region (2027-2032) Table 23. Global Radiation Injury Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 24. Global Radiation Injury Drugs Sales by Region (2021-2026) & (K Units) Table 25. Global Radiation Injury Drugs Sales by Region (2027-2032) & (K Units) Table 26. Global Radiation Injury Drugs Sales Market Share by Region (2021-2026) Table 27. Global Radiation Injury Drugs Sales Market Share by Region (2027-2032) Table 28. Global Radiation Injury Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Radiation Injury Drugs Revenue Market Share by Manufacturers (2021-2026) Table 30. Global Radiation Injury Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 31. Global Radiation Injury Drugs Sales Market Share by Manufacturers (2021-2026) Table 32. Global Radiation Injury Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 33. Global Radiation Injury Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 34. Global Radiation Injury Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 35. Global Radiation Injury Drugs Manufacturers, Product Type & Application Table 36. Global Radiation Injury Drugs Manufacturers' Establishment Date Table 37. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 38. Global Radiation Injury Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Radiation Injury Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Radiation Injury Drugs Revenue by Type (2021-2026) & (US$ Million) Table 41. Global Radiation Injury Drugs Revenue by Type (2027-2032) & (US$ Million) Table 42. Global Radiation Injury Drugs Revenue Market Share by Type (2021-2026) Table 43. Global Radiation Injury Drugs Revenue Market Share by Type (2027-2032) Table 44. Global Radiation Injury Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 45. Global Radiation Injury Drugs Sales by Type (2021-2026) & (K Units) Table 46. Global Radiation Injury Drugs Sales by Type (2027-2032) & (K Units) Table 47. Global Radiation Injury Drugs Sales Market Share by Type (2021-2026) Table 48. Global Radiation Injury Drugs Sales Market Share by Type (2027-2032) Table 49. Global Radiation Injury Drugs Price by Type (2021-2026) & (US$/Unit) Table 50. Global Radiation Injury Drugs Price by Type (2027-2032) & (US$/Unit) Table 51. Global Radiation Injury Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Radiation Injury Drugs Revenue by Application (2021-2026) & (US$ Million) Table 53. Global Radiation Injury Drugs Revenue by Application (2027-2032) & (US$ Million) Table 54. Global Radiation Injury Drugs Revenue Market Share by Application (2021-2026) Table 55. Global Radiation Injury Drugs Revenue Market Share by Application (2027-2032) Table 56. Global Radiation Injury Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 57. Global Radiation Injury Drugs Sales by Application (2021-2026) & (K Units) Table 58. Global Radiation Injury Drugs Sales by Application (2027-2032) & (K Units) Table 59. Global Radiation Injury Drugs Sales Market Share by Application (2021-2026) Table 60. Global Radiation Injury Drugs Sales Market Share by Application (2027-2032) Table 61. Global Radiation Injury Drugs Price by Application (2021-2026) & (US$/Unit) Table 62. Global Radiation Injury Drugs Price by Application (2027-2032) & (US$/Unit) Table 63. Windtree Therapeutics Inc Company Information Table 64. Windtree Therapeutics Inc Business Overview Table 65. Windtree Therapeutics Inc Radiation Injury Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Windtree Therapeutics Inc Radiation Injury Drugs Product Portfolio Table 67. Windtree Therapeutics Inc Recent Development Table 68. Tonix Pharmaceuticals Holding Corp Company Information Table 69. Tonix Pharmaceuticals Holding Corp Business Overview Table 70. Tonix Pharmaceuticals Holding Corp Radiation Injury Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Tonix Pharmaceuticals Holding Corp Radiation Injury Drugs Product Portfolio Table 72. Tonix Pharmaceuticals Holding Corp Recent Development Table 73. Synedgen Inc Company Information Table 74. Synedgen Inc Business Overview Table 75. Synedgen Inc Radiation Injury Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Synedgen Inc Radiation Injury Drugs Product Portfolio Table 77. Synedgen Inc Recent Development Table 78. PharmaIN Corp Company Information Table 79. PharmaIN Corp Business Overview Table 80. PharmaIN Corp Radiation Injury Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. PharmaIN Corp Radiation Injury Drugs Product Portfolio Table 82. PharmaIN Corp Recent Development Table 83. FirstString Research Inc Company Information Table 84. FirstString Research Inc Business Overview Table 85. FirstString Research Inc Radiation Injury Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. FirstString Research Inc Radiation Injury Drugs Product Portfolio Table 87. FirstString Research Inc Recent Development Table 88. North America Radiation Injury Drugs Revenue by Type (2021-2026) & (US$ Million) Table 89. North America Radiation Injury Drugs Revenue by Type (2027-2032) & (US$ Million) Table 90. North America Radiation Injury Drugs Sales by Type (2021-2026) & (K Units) Table 91. North America Radiation Injury Drugs Sales by Type (2027-2032) & (K Units) Table 92. North America Radiation Injury Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 93. North America Radiation Injury Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 94. North America Radiation Injury Drugs Revenue by Application (2021-2026) & (US$ Million) Table 95. North America Radiation Injury Drugs Revenue by Application (2027-2032) & (US$ Million) Table 96. North America Radiation Injury Drugs Sales by Application (2021-2026) & (K Units) Table 97. North America Radiation Injury Drugs Sales by Application (2027-2032) & (K Units) Table 98. North America Radiation Injury Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 99. North America Radiation Injury Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 100. North America Radiation Injury Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Radiation Injury Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 102. North America Radiation Injury Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 103. North America Radiation Injury Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 104. North America Radiation Injury Drugs Sales by Country (2021-2026) & (K Units) Table 105. North America Radiation Injury Drugs Sales by Country (2027-2032) & (K Units) Table 106. North America Radiation Injury Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 107. North America Radiation Injury Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 108. United States Radiation Injury Drugs Revenue (2021-2032) & (US$ Million) Table 109. Canada Radiation Injury Drugs Revenue (2021-2032) & (US$ Million) Table 110. Europe Radiation Injury Drugs Revenue by Type (2021-2026) & (US$ Million) Table 111. Europe Radiation Injury Drugs Revenue by Type (2027-2032) & (US$ Million) Table 112. Europe Radiation Injury Drugs Sales by Type (2021-2026) & (K Units) Table 113. Europe Radiation Injury Drugs Sales by Type (2027-2032) & (K Units) Table 114. Europe Radiation Injury Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 115. Europe Radiation Injury Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 116. Europe Radiation Injury Drugs Revenue by Application (2021-2026) & (US$ Million) Table 117. Europe Radiation Injury Drugs Revenue by Application (2027-2032) & (US$ Million) Table 118. Europe Radiation Injury Drugs Sales by Application (2021-2026) & (K Units) Table 119. Europe Radiation Injury Drugs Sales by Application (2027-2032) & (K Units) Table 120. Europe Radiation Injury Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 121. Europe Radiation Injury Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 122. Europe Radiation Injury Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Radiation Injury Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 124. Europe Radiation Injury Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 125. Europe Radiation Injury Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 126. Europe Radiation Injury Drugs Sales by Country (2021-2026) & (K Units) Table 127. Europe Radiation Injury Drugs Sales by Country (2027-2032) & (K Units) Table 128. Europe Radiation Injury Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 129. Europe Radiation Injury Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 130. Germany Radiation Injury Drugs Revenue (2021-2032) & (US$ Million) Table 131. France Radiation Injury Drugs Revenue (2021-2032) & (US$ Million) Table 132. U.K. Radiation Injury Drugs Revenue (2021-2032) & (US$ Million) Table 133. Italy Radiation Injury Drugs Revenue (2021-2032) & (US$ Million) Table 134. Netherlands Radiation Injury Drugs Revenue (2021-2032) & (US$ Million) Table 135. China Radiation Injury Drugs Revenue by Type (2021-2026) & (US$ Million) Table 136. China Radiation Injury Drugs Revenue by Type (2027-2032) & (US$ Million) Table 137. China Radiation Injury Drugs Sales by Type (2021-2026) & (K Units) Table 138. China Radiation Injury Drugs Sales by Type (2027-2032) & (K Units) Table 139. China Radiation Injury Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 140. China Radiation Injury Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 141. China Radiation Injury Drugs Revenue by Application (2021-2026) & (US$ Million) Table 142. China Radiation Injury Drugs Revenue by Application (2027-2032) & (US$ Million) Table 143. China Radiation Injury Drugs Sales by Application (2021-2026) & (K Units) Table 144. China Radiation Injury Drugs Sales by Application (2027-2032) & (K Units) Table 145. China Radiation Injury Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 146. China Radiation Injury Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 147. Asia Radiation Injury Drugs Revenue by Type (2021-2026) & (US$ Million) Table 148. Asia Radiation Injury Drugs Revenue by Type (2027-2032) & (US$ Million) Table 149. Asia Radiation Injury Drugs Sales by Type (2021-2026) & (K Units) Table 150. Asia Radiation Injury Drugs Sales by Type (2027-2032) & (K Units) Table 151. Asia Radiation Injury Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 152. Asia Radiation Injury Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 153. Asia Radiation Injury Drugs Revenue by Application (2021-2026) & (US$ Million) Table 154. Asia Radiation Injury Drugs Revenue by Application (2027-2032) & (US$ Million) Table 155. Asia Radiation Injury Drugs Sales by Application (2021-2026) & (K Units) Table 156. Asia Radiation Injury Drugs Sales by Application (2027-2032) & (K Units) Table 157. Asia Radiation Injury Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 158. Asia Radiation Injury Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 159. Asia Radiation Injury Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Asia Radiation Injury Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. Asia Radiation Injury Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. Asia Radiation Injury Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 163. Asia Radiation Injury Drugs Sales by Country (2021-2026) & (K Units) Table 164. Asia Radiation Injury Drugs Sales by Country (2027-2032) & (K Units) Table 165. Asia Radiation Injury Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 166. Asia Radiation Injury Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 167. Japan Radiation Injury Drugs Revenue (2021-2032) & (US$ Million) Table 168. South Korea Radiation Injury Drugs Revenue (2021-2032) & (US$ Million) Table 169. India Radiation Injury Drugs Revenue (2021-2032) & (US$ Million) Table 170. Australia Radiation Injury Drugs Revenue (2021-2032) & (US$ Million) Table 171. China Taiwan Radiation Injury Drugs Revenue (2021-2032) & (US$ Million) Table 172. Southeast Asia Radiation Injury Drugs Revenue (2021-2032) & (US$ Million) Table 173. SAMEA Radiation Injury Drugs Revenue by Type (2021-2026) & (US$ Million) Table 174. SAMEA Radiation Injury Drugs Revenue by Type (2027-2032) & (US$ Million) Table 175. SAMEA Radiation Injury Drugs Sales by Type (2021-2026) & (K Units) Table 176. SAMEA Radiation Injury Drugs Sales by Type (2027-2032) & (K Units) Table 177. SAMEA Radiation Injury Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 178. SAMEA Radiation Injury Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 179. SAMEA Radiation Injury Drugs Revenue by Application (2021-2026) & (US$ Million) Table 180. SAMEA Radiation Injury Drugs Revenue by Application (2027-2032) & (US$ Million) Table 181. SAMEA Radiation Injury Drugs Sales by Application (2021-2026) & (K Units) Table 182. SAMEA Radiation Injury Drugs Sales by Application (2027-2032) & (K Units) Table 183. SAMEA Radiation Injury Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 184. SAMEA Radiation Injury Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 185. SAMEA Radiation Injury Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. SAMEA Radiation Injury Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. SAMEA Radiation Injury Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. SAMEA Radiation Injury Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 189. SAMEA Radiation Injury Drugs Sales by Country (2021-2026) & (K Units) Table 190. SAMEA Radiation Injury Drugs Sales by Country (2027-2032) & (K Units) Table 191. SAMEA Radiation Injury Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 192. SAMEA Radiation Injury Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 193. Brazil Radiation Injury Drugs Revenue (2021-2032) & (US$ Million) Table 194. Argentina Radiation Injury Drugs Revenue (2021-2032) & (US$ Million) Table 195. Chile Radiation Injury Drugs Revenue (2021-2032) & (US$ Million) Table 196. Colombia Radiation Injury Drugs Revenue (2021-2032) & (US$ Million) Table 197. Peru Radiation Injury Drugs Revenue (2021-2032) & (US$ Million) Table 198. Saudi Arabia Radiation Injury Drugs Revenue (2021-2032) & (US$ Million) Table 199. Israel Radiation Injury Drugs Revenue (2021-2032) & (US$ Million) Table 200. UAE Radiation Injury Drugs Revenue (2021-2032) & (US$ Million) Table 201. Turkey Radiation Injury Drugs Revenue (2021-2032) & (US$ Million) Table 202. Iran Radiation Injury Drugs Revenue (2021-2032) & (US$ Million) Table 203. Egypt Radiation Injury Drugs Revenue (2021-2032) & (US$ Million) Table 204. Key Raw Materials Table 205. Raw Materials Key Suppliers Table 206. Radiation Injury Drugs Distributors List Table 207. Radiation Injury Drugs Customers List Table 208. Research Programs/Design for This Report Table 209. Authors List of This Report Table 210. Secondary Sources Table 211. Primary Sources List of Figures Figure 1. Radiation Injury Drugs Image Figure 2. Global Radiation Injury Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Radiation Injury Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. DG-3 Image Figure 5. Des-Asp Angiotensin 1 Image Figure 6. C-2E5 Image Figure 7. C-2E2 Image Figure 8. BMX-001 Image Figure 9. Aerosurf Image Figure 10. Others Image Figure 11. Global Radiation Injury Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Radiation Injury Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 13. Hospital Image Figure 14. Clinic Image Figure 15. ASCs Image Figure 16. Others Image Figure 17. Global Radiation Injury Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Radiation Injury Drugs Revenue (2021-2032) & (US$ Million) Figure 19. Global Radiation Injury Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Radiation Injury Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 21. Global Radiation Injury Drugs Revenue Market Share by Region (2021-2032) Figure 22. Global Radiation Injury Drugs Sales (2021-2032) & (K Units) Figure 23. Global Radiation Injury Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 24. Global Radiation Injury Drugs Sales Market Share by Region (2021-2032) Figure 25. US & Canada & Mexico Radiation Injury Drugs Sales YoY (2021-2032) & (K Units) Figure 26. Europe Radiation Injury Drugs Sales YoY (2021-2032) & (K Units) Figure 27. China Radiation Injury Drugs Sales YoY (2021-2032) & (K Units) Figure 28. Asia (Excluding China) Radiation Injury Drugs Sales YoY (2021-2032) & (K Units) Figure 29. South America, Middle East and Africa Radiation Injury Drugs Sales YoY (2021-2032) & (K Units) Figure 30. Global Radiation Injury Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 31. Global Radiation Injury Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 32. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Global Radiation Injury Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Radiation Injury Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Radiation Injury Drugs Revenue Market Share by Type (2021-2032) Figure 36. Global Radiation Injury Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Radiation Injury Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 38. Global Radiation Injury Drugs Sales Market Share by Type (2021-2032) Figure 39. Global Radiation Injury Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 40. Global Radiation Injury Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Radiation Injury Drugs Revenue Market Share by Application (2021-2032) Figure 42. Global Radiation Injury Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 43. Global Radiation Injury Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 44. Global Radiation Injury Drugs Sales Market Share by Application (2021-2032) Figure 45. North America Radiation Injury Drugs Revenue Share by Type (2021-2032) Figure 46. North America Radiation Injury Drugs Sales Share by Type (2021-2032) Figure 47. North America Radiation Injury Drugs Revenue Share by Application (2021-2032) Figure 48. North America Radiation Injury Drugs Sales Share by Application (2021-2032) Figure 49. North America Radiation Injury Drugs Revenue Share by Country (2021-2032) Figure 50. North America Radiation Injury Drugs Sales Share by Country (2021-2032) Figure 51. Europe Radiation Injury Drugs Revenue Share by Type (2021-2032) Figure 52. Europe Radiation Injury Drugs Sales Share by Type (2021-2032) Figure 53. Europe Radiation Injury Drugs Revenue Share by Application (2021-2032) Figure 54. Europe Radiation Injury Drugs Sales Share by Application (2021-2032) Figure 55. Europe Radiation Injury Drugs Revenue Share by Country (2021-2032) Figure 56. Europe Radiation Injury Drugs Sales Share by Country (2021-2032) Figure 57. China Radiation Injury Drugs Revenue Share by Type (2021-2032) Figure 58. China Radiation Injury Drugs Sales Share by Type (2021-2032) Figure 59. China Radiation Injury Drugs Revenue Share by Application (2021-2032) Figure 60. China Radiation Injury Drugs Sales Share by Application (2021-2032) Figure 61. Asia Radiation Injury Drugs Revenue Share by Type (2021-2032) Figure 62. Asia Radiation Injury Drugs Sales Share by Type (2021-2032) Figure 63. Asia Radiation Injury Drugs Revenue Share by Application (2021-2032) Figure 64. Asia Radiation Injury Drugs Sales Share by Application (2021-2032) Figure 65. Asia Radiation Injury Drugs Revenue Share by Country (2021-2032) Figure 66. Asia Radiation Injury Drugs Sales Share by Country (2021-2032) Figure 67. SAMEA Radiation Injury Drugs Revenue Share by Type (2021-2032) Figure 68. SAMEA Radiation Injury Drugs Sales Share by Type (2021-2032) Figure 69. SAMEA Radiation Injury Drugs Revenue Share by Application (2021-2032) Figure 70. SAMEA Radiation Injury Drugs Sales Share by Application (2021-2032) Figure 71. SAMEA Radiation Injury Drugs Revenue Share by Country (2021-2032) Figure 72. SAMEA Radiation Injury Drugs Sales Share by Country (2021-2032) Figure 73. Radiation Injury Drugs Value Chain Figure 74. Manufacturing Cost Structure Figure 75. Radiation Injury Drugs Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Years Considered Figure 79. Research Process Figure 80. Key Executives Interviewed

Scope & coverage.

Types
  • DG-3
  • Des-Asp Angiotensin 1
  • C-2E5
  • C-2E2
  • BMX-001
  • Aerosurf
  • Others
Applications
  • Hospital
  • Clinic
  • ASCs
  • Others
Companies covered
  • Windtree Therapeutics Inc
  • Tonix Pharmaceuticals Holding Corp
  • Synedgen Inc
  • PharmaIN Corp
  • FirstString Research Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Radiation Injury Drugs Market by Type
  3. 1.2.1 Global Radiation Injury Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 DG-3
  5. 1.2.3 Des-Asp Angiotensin 1
  6. 1.2.4 C-2E5
  7. 1.2.5 C-2E2
  8. 1.2.6 BMX-001
  9. 1.2.7 Aerosurf
  10. 1.2.8 Others
  11. 1.3 Radiation Injury Drugs Market by Application
  12. 1.3.1 Global Radiation Injury Drugs Market Size by Application, 2021 VS 2025 VS 2032
  13. 1.3.2 Hospital
  14. 1.3.3 Clinic
  15. 1.3.4 ASCs
  16. 1.3.5 Others
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 Radiation Injury Drugs Market Dynamics
  1. 2.1 Radiation Injury Drugs Industry Trends
  2. 2.2 Radiation Injury Drugs Industry Drivers
  3. 2.3 Radiation Injury Drugs Industry Opportunities and Challenges
  4. 2.4 Radiation Injury Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Radiation Injury Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Radiation Injury Drugs Revenue by Region
  3. 3.2.1 Global Radiation Injury Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Radiation Injury Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Radiation Injury Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Radiation Injury Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Radiation Injury Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Radiation Injury Drugs Sales by Region
  9. 3.4.1 Global Radiation Injury Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Radiation Injury Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Radiation Injury Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Radiation Injury Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Radiation Injury Drugs Revenue by Manufacturers
  2. 4.1.1 Global Radiation Injury Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Radiation Injury Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Radiation Injury Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Radiation Injury Drugs Sales by Manufacturers
  6. 4.2.1 Global Radiation Injury Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Radiation Injury Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Radiation Injury Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Radiation Injury Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Radiation Injury Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Radiation Injury Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Radiation Injury Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Radiation Injury Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Radiation Injury Drugs Market CR5 and HHI
  16. 4.8.2 2025 Radiation Injury Drugs Tier 1, Tier 2, and Tier 3
5 Radiation Injury Drugs Market by Type
  1. 5.1 Global Radiation Injury Drugs Revenue by Type
  2. 5.1.1 Global Radiation Injury Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Radiation Injury Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Radiation Injury Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Radiation Injury Drugs Sales by Type
  6. 5.2.1 Global Radiation Injury Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Radiation Injury Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Radiation Injury Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Radiation Injury Drugs Price by Type
6 Radiation Injury Drugs Market by Application
  1. 6.1 Global Radiation Injury Drugs Revenue by Application
  2. 6.1.1 Global Radiation Injury Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Radiation Injury Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Radiation Injury Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Radiation Injury Drugs Sales by Application
  6. 6.2.1 Global Radiation Injury Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Radiation Injury Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Radiation Injury Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Radiation Injury Drugs Price by Application
7 Company Profiles
  1. 7.1 Windtree Therapeutics Inc
  2. 7.1.1 Windtree Therapeutics Inc Company Information
  3. 7.1.2 Windtree Therapeutics Inc Business Overview
  4. 7.1.3 Windtree Therapeutics Inc Radiation Injury Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Windtree Therapeutics Inc Radiation Injury Drugs Product Portfolio
  6. 7.1.5 Windtree Therapeutics Inc Recent Developments
  7. 7.2 Tonix Pharmaceuticals Holding Corp
  8. 7.2.1 Tonix Pharmaceuticals Holding Corp Company Information
  9. 7.2.2 Tonix Pharmaceuticals Holding Corp Business Overview
  10. 7.2.3 Tonix Pharmaceuticals Holding Corp Radiation Injury Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Tonix Pharmaceuticals Holding Corp Radiation Injury Drugs Product Portfolio
  12. 7.2.5 Tonix Pharmaceuticals Holding Corp Recent Developments
  13. 7.3 Synedgen Inc
  14. 7.3.1 Synedgen Inc Company Information
  15. 7.3.2 Synedgen Inc Business Overview
  16. 7.3.3 Synedgen Inc Radiation Injury Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Synedgen Inc Radiation Injury Drugs Product Portfolio
  18. 7.3.5 Synedgen Inc Recent Developments
  19. 7.4 PharmaIN Corp
  20. 7.4.1 PharmaIN Corp Company Information
  21. 7.4.2 PharmaIN Corp Business Overview
  22. 7.4.3 PharmaIN Corp Radiation Injury Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 PharmaIN Corp Radiation Injury Drugs Product Portfolio
  24. 7.4.5 PharmaIN Corp Recent Developments
  25. 7.5 FirstString Research Inc
  26. 7.5.1 FirstString Research Inc Company Information
  27. 7.5.2 FirstString Research Inc Business Overview
  28. 7.5.3 FirstString Research Inc Radiation Injury Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 FirstString Research Inc Radiation Injury Drugs Product Portfolio
  30. 7.5.5 FirstString Research Inc Recent Developments
8 North America
  1. 8.1 North America Radiation Injury Drugs Market Size by Type
  2. 8.1.1 North America Radiation Injury Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Radiation Injury Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Radiation Injury Drugs Price by Type (2021-2032)
  5. 8.2 North America Radiation Injury Drugs Market Size by Application
  6. 8.2.1 North America Radiation Injury Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Radiation Injury Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Radiation Injury Drugs Price by Application (2021-2032)
  9. 8.3 North America Radiation Injury Drugs Market Size by Country
  10. 8.3.1 North America Radiation Injury Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Radiation Injury Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Radiation Injury Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Radiation Injury Drugs Market Size by Type
  2. 9.1.1 Europe Radiation Injury Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Radiation Injury Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Radiation Injury Drugs Price by Type (2021-2032)
  5. 9.2 Europe Radiation Injury Drugs Market Size by Application
  6. 9.2.1 Europe Radiation Injury Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Radiation Injury Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Radiation Injury Drugs Price by Application (2021-2032)
  9. 9.3 Europe Radiation Injury Drugs Market Size by Country
  10. 9.3.1 Europe Radiation Injury Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Radiation Injury Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Radiation Injury Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Radiation Injury Drugs Market Size by Type
  2. 10.1.1 China Radiation Injury Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Radiation Injury Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Radiation Injury Drugs Price by Type (2021-2032)
  5. 10.2 China Radiation Injury Drugs Market Size by Application
  6. 10.2.1 China Radiation Injury Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Radiation Injury Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Radiation Injury Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Radiation Injury Drugs Market Size by Type
  2. 11.1.1 Asia Radiation Injury Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Radiation Injury Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Radiation Injury Drugs Price by Type (2021-2032)
  5. 11.2 Asia Radiation Injury Drugs Market Size by Application
  6. 11.2.1 Asia Radiation Injury Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Radiation Injury Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Radiation Injury Drugs Price by Application (2021-2032)
  9. 11.3 Asia Radiation Injury Drugs Market Size by Country
  10. 11.3.1 Asia Radiation Injury Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Radiation Injury Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Radiation Injury Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Radiation Injury Drugs Market Size by Type
  2. 12.1.1 SAMEA Radiation Injury Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Radiation Injury Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Radiation Injury Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Radiation Injury Drugs Market Size by Application
  6. 12.2.1 SAMEA Radiation Injury Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Radiation Injury Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Radiation Injury Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Radiation Injury Drugs Market Size by Country
  10. 12.3.1 SAMEA Radiation Injury Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Radiation Injury Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Radiation Injury Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Radiation Injury Drugs Value Chain Analysis
  2. 13.1.1 Radiation Injury Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Radiation Injury Drugs Production Mode & Process
  6. 13.2 Radiation Injury Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Radiation Injury Drugs Distributors
  9. 13.2.3 Radiation Injury Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst